Putting the 'Q' in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures

被引:25
|
作者
Mann, Rachel [1 ]
Gilbody, Simon [1 ]
Richards, David [1 ]
机构
[1] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England
基金
英国医学研究理事会;
关键词
health related utility; EQ-5D; SF-6D; quality of life; outcomes measurement; SEVERITY; PHQ-9; COST; CARE;
D O I
10.1007/s00127-008-0463-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Generic health preference measures that capture quality of life improvements in depression are important for economic analysis of new technologies. To compare two widely used preference measures, the EQ-5D and SF-6D, in terms of their dimensions and health utility values. EQ-5D and SF-6D data collected from 114 patients with depression, who participated in a cluster, randomised controlled trial to evaluate a collaborative care intervention in UK, primary care practices. Utilities were examined across the whole sample and by level of depression severity using the PHQ-9. Depression was associated with disutility at baseline. At 3 month follow-up mean utility increased 0.147 for EQ-5D and 0.082 for SF-6D. Health gains were observed in patients in remission from depression and those with the mildest level of depression severity. Both generic preference measures were sensitive to health gains in depression within a relatively short follow-up period; larger health gain was observed for the EQ-5D.
引用
收藏
页码:569 / 578
页数:10
相关论文
共 50 条
  • [41] The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D
    Sach, T. H.
    Barton, G. R.
    Doherty, M.
    Muir, K. R.
    Jenkinson, C.
    Avery, A. J.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (01) : 189 - 196
  • [42] A comparison of the performance of the EQ-5D and SF-6D for individuals aged ≥ 45 years
    Barton, Garry R.
    Sach, Tracey H.
    Avery, Anthony J.
    Jenkinson, Claire
    Doherty, Michael
    Whynes, David K.
    Muir, Kenneth R.
    HEALTH ECONOMICS, 2008, 17 (07) : 815 - 832
  • [43] Comparison of SF-6D and EQ-5D utilities in osteoporotic hip fracture patients
    Golicki, D.
    Latek, M. M.
    VALUE IN HEALTH, 2007, 10 (06) : A397 - A398
  • [44] Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
    Kim, Sang-Kyu
    Kim, Seon-Ha
    Jo, Min-Woo
    Lee, Sang-il
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13
  • [45] Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia
    Seow, Lee Seng Esmond
    Lau, Jue Hua
    Abdin, Edimansyah
    Verma, Swapna K.
    Tan, Kelvin Bryan
    Subramaniam, Mythily
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (07) : 813 - 821
  • [46] COMPARING THE PERFORMANCE OF THE SF-6D AND EQ-5D ACROSS DISEASES
    Ferreira, L.
    Ferreira, P.
    Pereira, L.
    VALUE IN HEALTH, 2011, 14 (07) : A427 - A427
  • [47] Comparison of Trends in US Health-Related Quality of Life Over the 2000s Using the SF-6D, HALex, EQ-5D, and EQ-5D Visual Analog Scale Versus a Broader Set of Symptoms and Impairments
    Stewart, Susan T.
    Cutler, David M.
    Rosen, Allison B.
    MEDICAL CARE, 2014, 52 (12) : 1010 - 1016
  • [48] EQ-5D and SF-6D performance in different patient groups
    Ferreira, Pedro L.
    Ferreira, Lara N.
    Pereira, Luis N.
    QUALITY OF LIFE RESEARCH, 2012, 21 : 7 - 7
  • [49] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Kontodimopoulos, Nick
    Argiriou, Michalis
    Theakos, Nikolaos
    Niakas, Dimitris
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (04): : 383 - 391
  • [50] EQ-5D and SF-6D health status measures correlate with disease activity and damage in systemic lupus erythematosus
    Aggarwal, Rohit
    Block, Joel A.
    Jolly, Meenakshi
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4287 - 4287